FDA Approves Tremfya for Active Crohn Disease in Adults

Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn disease

aldoguerra851@gmail.com aldoguerra851@gmail.com
Mar 24, 2025 - 20:00
5 0
Tremfya is the first and only interleukin-23 inhibitor offering both subcutaneous and intravenous induction options for Crohn disease
Read More